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OUTREACH WORK 
GETS MODERN
INNOVATIVE NEEDLE EXCHANGE ON THE STREETS OF DUBLIN
‘It is a project that is consistent with the 
practice and principles of harm reduction, 
and its street-based focus provides 
culturally relevant opportunities for 
interaction and communication...’

This month’s cover story (page 8) documents a logical approach to something that should be straightforward,
but so often isn’t. How often do services wait for clients to come knocking when they’re hardly likely to? True
outreach means seeking out the people most in need of services and literally reaching out to them, while being
mindful of every aspect of their dignity. Seeing evidence of the Ana Liffey Project’s work on the streets of Dublin
impressed Stephen Parkin enough to find out more, and to think about how such logical, street-based harm
reduction initiatives could be transplanted elsewhere. ‘All our staff are very client focused – we’re constantly
seeking new ways to reach marginalised clients,’ says the project’s director, Tony Duffin, and it’s this constant
quest for innovation that’s so relevant.
With this in mind, we’d like to invite your contributions to our new ‘good practice exchange’, to be featured in
the magazine and on our website. Do you have a successful initiative that you’d like to share with other readers –
maybe a familiar area of practice that you've approached a little differently or with a certain flair, or an innovative
twist that’s worked particularly well for you? We all spend too long reinventing the wheel – please share your
ideas with us. You might just spark a new initiative elsewhere in the country.
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Minimum unit pricing will ‘not be taken forward at
this moment’, the government has announced in a
statement on the outcome of its alcohol strategy
consultation. There will also be no ban on multi-buy
promotions. 
There was not enough ‘concrete evidence’ that
minimum pricing would help reduce alcohol harm without
penalising responsible drinkers, crime prevention minister
Jeremy Browne told MPs. However alcohol sales below
the level of alcohol duty plus VAT would be banned from
next spring, meaning it would no longer be legal to sell a
can of lager ‘for less than about 40 pence’. 
There was also ‘a lack of convincing evidence’ that a
ban on multi-buy promotions would have a significant
effect on reducing consumption, he said, adding that its
introduction would be unreasonable ‘at a time when
responsible families are trying hard to balance their
household budgets’. 
The government would tackle irresponsible
promotions by making mandatory licensing conditions
more effective, he stated, and promote responsible
drinking by ‘raising customer awareness of the
availability of small servings’. It would also work with
‘high harm local alcohol action areas’ to improve
enforcement, strengthen partnerships and ‘increase good
practice of what works locally’. 
The alcohol industry now had ‘an opportunity to
demonstrate what more it can do to reduce harms
associated with problem drinking’, he continued. ‘We
want fair and effective policies,’ he said. ‘We are not in
the business of making laws that do not work.’
The statement was instantly welcomed by industry
bodies. British Beer and Pub Association chief executive
Brigid Simmonds said that the decision not to ban multi-
buy promotions recognised ‘the lack of evidence that this
encourages over-consumption, rather than providing
value and convenience for shoppers’, while Portman
Group chief executive Henry Ashworth said that ‘through
a series of voluntary pledges aimed at improving public
health, the industry has proven itself to be committed
and willing partners and welcomes the opportunity to
continue this successful approach going forward.’ 
The industry’s win, however, was a ‘grave loss for the
public health of the nation’, said Alcohol Concern chief
executive Eric Appleby. ‘The alcohol industry must be
congratulating themselves on their success at lobbying
government to bin minimum unit pricing.’
Abandoning the plans amounted to a public health
‘catastrophe’, he said. ‘In the government’s own alcohol
strategy it committed to tackling alcohol misuse by
making tough decisions, including introducing minimum
unit pricing, a policy proven to cut crime and save lives.
Sadly, with this announcement, cheap alcohol will
continue to be sold at pocket money prices.’
The government’s decision also led to an
announcement by Cancer Research UK, the Faculty of
Public Health and the UK Health Forum that they were
pulling out of the government’s public health
responsibility deal alcohol network, along with network
co-chair Dr Nick Sheron, head of clinical hepatology at
the University of Southampton. ‘Talk of “punishing the
hard worker” who can afford few other pleasures than a
pint of mild is a red herring,’ said a joint statement. ‘It is
our most deprived communities who pay the highest
price for cheap alcohol through the consequences of
street crime, violence and younger people developing
alcohol-related health problems.’
Organisations including Alcohol Concern, the British
Medical Association, the Royal College of Physicians and
the British Liver Trust refused to sign up to the
controversial deal in 2011 (DDN, April 2011, page 4),
accusing the government of allowing the drinks industry
to dictate health policy. 
See news focus, page 6
NOT FOILED AGAIN
The government has accepted the
ACMD’s advice to allow for the provision
of foil by treatment providers ‘subject to
the strict condition that it is part of
structured efforts to get people into
treatment and off drugs’, home secretary
Theresa May has announced. The
government would also introduce
mechanisms to monitor take-up and
adherence to conditions, she said. ‘The
provision of foil in needle exchange and
drug treatment services can contribute to
a reduction in drug injecting and
associated health risks, such as
exposure to blood born viruses, vein
collapse and overdose,’ said DrugScope
chief executive Martin Barnes. ‘Support
that enables heroin and other drug users
to reduce the risks to themselves and
others can be the catalyst for engaging
with treatment and support for recovery.’ 
HEP C HELP
A free, confidential helpline for prisoners
has been launched by the Hepatitis C
Trust. The helpline, which will be open
five days a week on 0800 999 2052,
allows the trust to ‘reach out to a highly
affected population’, said head of patient
support services, Samantha May. ‘What
we offer is the facility for prisoners to
speak with their peers who can
empathise with the stigmatisation that
someone can face when they have the
virus,’ she said. ‘We can answer their
questions and tell it like it is.’ The trust
has also produced a new briefing for
London’s health and wellbeing boards
which urges local authorities to improve
commissioning, promote testing and
encourage training. Councils had an
‘unprecedented opportunity’, said trust
chief executive Charles Gore. ‘If we
diagnose and treat those infected, we
could virtually eradicate the virus within a
generation.’ Reducing health inequalities
in London by addressing hepatitis C at
www.hepctrust.org.uk
GET NETWORKING
A new website has been launched by the
Alcohol Health Network to help reduce
alcohol-related harm in workplaces and
the community. Founded by former
Alcohol Concern chief executive Don
Shenker, the network works with
companies and public health teams to
help drinkers understand and reduce
their drinking levels via online self-
assessment tools, training and advice.
www.alcoholhealthnetwork.org.uk
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NEWS IN BRIEF Minimum pricing ‘will
not be taken forward’
‘Not enough concrete
evidence that mini -
mum pricing would
help reduce alcohol
harm without 
penal is ing respon -
sible drinkers.’ 
Jeremy Browne, MP
MARIJUANA MOVE
As DDN went to press, it was
announced that Uruguay’s House of
Representatives had passed a bill to
legalise marijuana. If approved by the
Senate, Uruguay will be the first country
to regulate the sale, production and
distribution of marijuana.
HIV WARNING
A ‘significant’ increase in injecting rates
among gay men could lead to sharp
rises in HIV levels, according to a report
from the National Aids Trust (NAT).
Earlier this year NAT wrote to London
councils warning of the ‘rapid rise’ in
the use of drugs like crystal meth and
mephedrone in parts of London’s gay
scene, coupled with high rates of
needle-sharing and lack of appropriate
services (DDN, April, page 6). ‘We need
drugs and sexual health services to
work together to meet the needs of gay
men,’ said NAT director of policy and
campaigns, Yusef Azad. HIV and injecting
drug use at www.nat.org.uk
SEPARATE LIVES
The Netherlands’ approach to drug policy
helped to keep cannabis users separate
from ‘hard drug dealers’, according to a
report from the Open Society
Foundations (OSF). Just 14 per cent of
Dutch cannabis users reported being
able to obtain other drugs from their
suppliers, compared to more than 50 per
cent in Sweden, says Coffee shops and
compromise: separated illicit drug
markets in the Netherlands. ‘As other
countries and local jurisdictions consider
reforming their laws, it’s possible that
the Netherlands’ past offers a guide for
the future,’ said director of the OSF’s
global drug policy programme, Kasia
Malinowska-Sempruch. Report at
www.opensocietyfoundations.org
WHAT IS RECOVERY?
Birmingham-based UK Recovery Radio
(DDN, March, page 17) has released its
second ‘Purple Bull’ podcast – What is
recovery? – which focuses on the role of
harm reduction. Listen at
recoveryradio.blogspot.co.uk
ALL CHANGE AT CRI
CRI’s deputy chief executive David
Biddle will take the top job at the
charity on 1 October, following David
Royce’s decision to pursue a part-time
role in the voluntary sector.
NEWS IN BRIEF
Drugs agencies have reacted with concern to the number
of recent deaths thought to involve PMA, which can be
present in ecstasy tablets or pills being sold as ecstasy.
Deaths have been reported in England, Scotland and
Northern Ireland in recent weeks. 
PMA can take longer to have an effect than ecstasy,
with the risk that people take repeat doses in the belief
that the drugs are not working. The Department of Health
has issued a health alert to NHS and public health
networks about ‘reports across regions in the UK of cases
of hospitalisations and sudden deaths linked to the use of
ecstasy-like pills. It has been reported that pills taken by
those affected have contained, either alone or in
combination, para-methoxyamphetamine (PMA), MDMA
(the usual active ingredient expected in “ecstasy” pills), or
other ecstasy-like stimulants.’
The pills reported in recent cases have ‘been described
with a variety of colours and with a variety of different
logos stamped on them’, says the document, with
warnings issued about ‘pink ecstasy’ tablets and, in
Scotland and Northern Ireland, ‘green Rolexes’. 
‘With the festival season under way, those who are
using ecstasy need to be extra vigilant,’ said DrugScope
chief executive Martin Barnes. ‘There is no way of knowing
whether or not a pill contains PMA.’
Meanwhile, new figures from the Home Office have led
the government to claim that drug use in England and
Wales is at its ‘lowest level since records began’. Just over
8 per cent of adults are estimated to have used an illicit
drug in the last year, compared to more than 11 per cent in
1996, according to Drug misuse: findings from the 2012/13
crime survey for England and Wales. In 2012-2013, 2.8 per
cent of 16 to 59-year-olds were defined as frequent drug
users – based on having taken any illicit drug more than
once a month on average – down from 3.3 per cent in
2011-12.
The statistics are based on Crime survey interviews with
around 21,000 adults aged 16 to 59. Questions on use of
the legal drugs salvia and nitrous oxide were added for the
first time and revealed that more than 6 per cent of 16 to
24-year-olds had taken nitrous oxide in the last year and
more than 1 per cent had taken salvia. 
‘It is worrying that the report shows there is a
disproportionate number of people aged between 16 and
24 taking these types of drugs, compared to the overall
number of 16 to 59-year-olds using legal highs,’ said
regional development manager at Swanswell, Jo Woods.
‘We welcome this report and are pleased to see the Home
Office recognising the developing problem.’
Report at www.gov.uk
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PMA in ecstasy tablets warning
The government has published plans to make it easier to
prosecute people who drive under the influence of drugs.
A new offence of ‘driving with a specified controlled drug
in the body above the specified limit for that drug’ is to be
introduced, designed to ‘reduce the wasted time, effort
and expense’ of failed prosecutions. 
The proposals are contained in a consultation
document, which also looks at penalties for driving when
impaired by certain prescribed drugs, although the
government has stressed that drivers who had taken
‘properly prescribed’ medicines would not be penalised. 
The consultation sets out a ‘zero tolerance’ approach to
driving under the influence of cannabis, MDMA, cocaine,
ketamine, LSD, methamphetamine, benzoylecgonine,
heroin and diamorphine, with limits set at the ‘lowest
level at which a valid and reliable analytical level can be
obtained’ but designed to rule out ‘passive consumption’
or ‘accidental exposure’. 
There will also be a limit for amphetamine, as yet to be
confirmed, along with limits for eight controlled drugs that
‘have recognised and widespread medical uses’ but which
can also affect the ability to drive, including methadone,
morphine, temazepam and diazepam. Penalties will include
an automatic driving ban of at least a year, as well as a
maximum fine of £5,000 and potential custodial sentences. 
Although police will not be able to conduct random
tests, they will have the power to administer a preliminary
drug test if someone has been in an accident, committed a
traffic offence, or if the officer ‘suspects that a driver has a
drug in his body or is under the influence of some drug’.
Police will be allowed to administer up to three
preliminary saliva tests, to be followed by arrest and the
requirement for a blood test if positive. 
‘Drug driving is a menace which devastates families
and ruins lives,’ said roads minister Stephen Hammond.
‘That is why we are proposing to take a zero tolerance
approach with those who drive under the influence of
illegal drugs and sending a clear message that this
behaviour will not be tolerated.’
The government has also launched a consultation on
the prescription drug tramadol, saying that it wants to
make it a class C drug while ensuring it remains ‘available
to those who need it as a prescription medicine’. The
announcement follows a recommendation by the Advisory
Council on the Misuse of Drugs (ACMD) that the painkiller
should be placed in Schedule 3 of the Misuse of Drugs
Regulations, which allows controlled substances to be
prescribed and legally possessed. 
The ACMD had expressed concern at the misuse of
tramadol, with the number of deaths involving the drug
nearly doubling – from 83 to 154 – between 2008 and 2011. 
Drug driving consultation at
www.gov.uk/government/consultations/drug-driving-
proposed-regulations, until 17 September.
Tramadol consultation at
www.gov.uk/government/consultations/scheduling-of-
tramadol-and-exemptions-for-temazepam-prescriptions,
until 11 October. 
Government consults on proposals
for new drug-driving offences
WHEN THE GOVERNMENT PUBLISHED ITS
ALCOHOL STRATEGY LAST YEAR, many people
were surprised to find that it contained a commitment
to introducing minimum unit pricing (MUP) (DDN, April
2012, page 4). But now, almost 18 months later, MUP
is once again seemingly off the agenda.
Although it remains ‘a policy under consideration,’
according to crime prevention minister Jeremy
Browne’s carefully worded statement to the House of
Commons, it will ‘not be taken forward at this time’
(see news story, page 4). While lack of evidence has
been cited as the reason, even the government’s own
Public Health England body has expressed
disappointment and pledged to ‘take forward a
comprehensive and scientific review of all the
available evidence’ to inform any final decision.
The University of Sheffield has also published
research claiming that the government’s alternative
measure – a ban on selling alcohol below the level
of the tax payable on it – would have a ‘small
impact’, as just 1.3 per cent of units sold would fall
below the threshold. 
When the rumours started earlier this year that the
government was planning to abandon MUP, much of
the talk was about the rise of Nigel Farage – often
photographed with a pint in his hand – and UKIP, and
the desire to not be seen as ‘anti-booze’ or out of
touch with ordinary people. But now the discussion
has turned back to a far more long-standing and
intractable obstacle – the sheer might of the drinks
industry – with a joint statement from Cancer
Research UK, the Faculty of Public Health and others
saying that it was ‘perfectly clear that MUP has fallen
victim to a concerted and shameful campaign of
lobbying’ by sections of the industry happy to put
profits ‘before health and public safety’.
‘One thing is undoubtedly the power and
influence of the industry,’ Alcohol Concern chief
executive Eric Appleby tells DDN. ‘We know they’ve
put massive resources into lobbying. But it also
appears that MUP is a bit of a victim of internal
divisions in the Conservative party, with certain
ministers in favour and then against. When the news
first came out that they were thinking of dropping it,
it coincided with a bit of caballing between various
people like Theresa May, Andrew Lansley and
Micheal Gove, so there’s internal politics in this as
well. But what it all boils down to, again, is that
public health is way down at the bottom of the
agenda when it comes to what’s important to them.’
What does his organisation make of the
commitments the government has made, such as
banning the sale of alcohol below the level of duty
plus VAT, or ‘facilitating local action’? ‘Banning sales
below duty has absolutely no impact whatsoever,’ he
states. ‘It will just do nothing. I think the reckoning
[from researchers at the University of Sheffield] was
that it would save 15 lives a year, instead of the 3,000
you’d get with MUP. It’s just a very flimsy fig leaf.’
Local action, meanwhile, relies on ‘good local
people’, he points out. ‘There are some good
examples around, obviously, but not everywhere are
there people with the understanding and resources.
We know that the whole thing with alcohol – and
why it’s different to drugs – is that it’s about whole-
population approaches, and you don’t get that just
from local action. You can’t knock it, but on its own
it’s not the answer.’
A vital function of minimum pricing has been to
provide a focal point for campaigners and a means
of unifying the message. Can it still do that now? ‘I
think it can – almost even more so,’ he says. ‘The
dropping of it has been done in such a way that it’s
almost become a cause célèbre. The government’s
arguments that there’s not enough evidence are
plainly just wrong. The fact that the government
have said they’re not doing it doesn’t lessen the
arguments for it in any way, and the very obvious
sense that they’ve just bowed down to the alcohol
industry is only going to fire people up more.’
He told DDN in June (page 16) that minimum
pricing was ‘not going to go away’. Is that
something he still believes? ‘Absolutely,’ he says.
‘And I can tell you that we’re not going to go away
either, and other members of the Alcohol Health
Alliance are not going to go away. We’re gearing up
to take it on even more strongly.’ 
So what happens now? ‘Obviously we’re going to
do some planning over the next few weeks about what
we do next, but at the moment we’re looking at things
like party manifestos for the next election,’ he says.
‘The Coalition haven’t actually ditched it – they’ve
backed off a bit and said that they’re just not doing it
right now – so if that’s the case they can at least put it
back in their manifestos for the next election. 
‘We know those aren’t necessarily worth that
much, but nonetheless it’s one way of keeping the
discussion going, keeping it in the forefront of
debate. And just making sure that – every step of
the way – they’re confronted by the fact that there’s
evidence that it works, and that none of the
alternatives can do the same job.’ 
Modelled income group-specific impacts of
alcohol minimum unit pricing in England 2014/15 at
www.shef.ac.uk/news/nr/below-cost-selling-ban-
1.294086
Last month saw yet another chapter in the ‘will they, won’t they?’ saga of minimum
unit pricing for alcohol, when the government announced it was shelving plans for
its introduction. DDN considers what might happen next
News focus | Analysis
IS MINIMUMPRICING
DEAD IN THE WATER?
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‘The government’s
arguments that
there’s not enough
evidence are plainly
just wrong.’
ERIC APPLEBY, 
ALCOHOL CONCERN
I became
interested in
working with
people who
develop
problems due
to their drug
and alcohol use
very early in my
GP career. 
However a significant number of GPs do not
work with people who use drugs and alcohol.
On the one hand there are practices like
ours, in which all of us regard this work as a
priority and where a few years ago our list
was closed, unless the person had a drug
problem! This compares with others where,
from the outset, it is clear that ‘your sort’
isn’t wanted. Why the difference?
Medical education plays a significant part
in attitudes – as undergraduates we receive
very little teaching on drug and alcohol
problems.  Although this has improved a
little over the past few years, there is still a
great deal more that could be delivered, as
evidence suggests that young doctors are
quite happy to engage in this role. 
At a postgraduate level it is fairly hit and
miss. I was fortunate to have a GP
postgraduate tutor, Dr Ian Fletcher, who
passionately believed in primary care
‘substance misuse services’ as we called it
then. He arranged a session for the West
Midland GP registrars and one of his
patients agreed to come along and share his
experiences with us. This was a real eye
opener to me, allowing me to see drug use
not as a self-inflicted problem but as an
attempt by some individuals to try and deal
with the trauma they face or experience as
they go through life.
Dr Clare Gerada, the current chair of the
RCGP council, has been a leading light in
encouraging primary care to provide good
quality care around substance use. She is also
keen to increase the length of GP
postgraduate training from three to four or
even to five years. This would provide an ideal
opportunity for the RCGP drug dependence
and alcohol training – currently optional for
both GP registrars and established GPs – to
be a part of the core curriculum.
Another problem relates to GP contracts.
The vast majority of GP practices have either
GMS (General Medical Services) contracts
which apply across the country and do not
include or specify providing treatment for
drug or alcohol problems; or PMS (Personal
Medical Services) contracts which are locally
agreed for a range of other services above
and beyond GMS – but again, many would
not have a specific substance misuse
category.  This doesn’t mean GPs can ignore
the physical or mental health problems of
people with drug and alcohol problems but
they are not obliged to offer OST, community
alcohol detoxifications etc unless they have
signed up to specific local contracts. 
There also remains a cohort of (often
older) GPs in practice who trained at a time
when GPs were actively discouraged from
getting involved in this field. I hope that as
time goes by they are being replaced by
more receptive GPs and that it will become
as normal to work with those with drug and
alcohol problems, as it is to treat someone
with diabetes or hypertension.
For this to occur the training needs to be
right, the support structures from
commissioners, drug workers, and the more
experienced GPs need to be in place and the
current investment in services needs to be
maintained. Given this, my aspiration is that
in time, the maverick GPs will be those that
are not involved in working with drug and
alcohol patients. Until then, I will continue
to educate and inform all GPs about
providing primary care treatment to this
interesting group of patients, giving them
the chance to recover from problematic drug
and alcohol use in their own communities.
For more information about the RCGP
Substance Misuse and Allied Health
certificate courses in the management of
drug and alcohol misuse, see
http://www.smmgp.org.uk/html/rcgp.php
Steve Brinksman is a GP in Birmingham,
clinical lead of SMMGP, www.smmgp.org.uk,
and RCGP regional lead in substance misuse
for the West Midlands.
Post-its from Practice
‘Some do, some don’t…’
All GPs should see involvement in drug and alcohol
treatment as the norm, says Dr Steve Brinksman
MEDIA SAVVY
WHO’S BEEN SAYING WHAT..?
Have you been stopped and searched by the police recently? If
you are a white, middle-class resident of, say, Tenterden or
Totnes, then almost certainly not. If you are a hoodie-wearing
black teenager, often to be found out on the streets after
midnight in Tottenham, then the chances are pretty high that
you have. So, is this a function of ethnicity or of relative crime
rates? Common sense would suggest the latter.
Philip Johnston, Telegraph, 1 July 
Azelle Rodney was a violent drug dealer on his way to rob a rival
gang at gunpoint when he was shot dead by police. Oh dear,
how sad, never mind. …Naturally, the usual suspects are lining
up to turn this vile little gangster into the latest cause célèbre to
bash the Old Bill. BBC London, Channel 4 and the Guardianistas
are filling their boots… In his line of work, getting shot is an
occupational hazard. If it hadn’t been the Old Bill, it may well
have been a Colombian hitman. Or one of his closest associates,
off his face on heroin.
Richard Littlejohn, Mail, 8 July
Why Theresa [May] takes advice on drugs at all is a mystery. I
suppose it’s nice to get out and have some meetings with
experts, even if their input is superfluous.
Grace Dent, Independent, 3 July 
While tabloid coverage of the mephedrone craze focused mainly
on the risk of death, the less extreme side of the story – that
people who wouldn’t have touched illicit chemicals began
hoovering up legal ones with gusto – went largely unreported…
Perhaps legalisation remains the best solution for society as a
whole – but, at least through my anecdotal periscope, it won’t
result in nirvana. British people like to boogie, and aren’t too
good at stopping.
Memphis Barker, Independent, 1 July
In a complete inversion of morality, modern welfare punishes
the diligent and rewards the feckless. That profound unfairness
is why the coalition has been so right to embark on a major
programme of welfare reform under the combative Iain Duncan
Smith, through sanctions on the workshy, limits to housing
benefit claims and the withdrawal of subsidies for spare
bedrooms.
Leo McKinstry, Express, 18 July
Criminals will not stop their crimes, change course and become
honest tax-paying citizens if drugs were legalised. Although
there may be freedom of choice to use dangerous substances
there can be no freedom from the consequences. International
drug control is working; fewer than 6 per cent of people globally
use drugs regularly and legalisation is not the answer.
Ian Oliver, Herald Scotland, 16 July
How many times do we keep trying to save people who don’t
want to be saved? How many times do we bring them back from
the brink to show them what a decent life is, only for them to
vomit all over it after yet another bottle of gin? 
Carole Malone, Mirror, 14 July
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I
f you’ve visited Dublin recently, you may have noticed that
something innovative is afoot on the streets of Ireland’s capital
city – quite literally. The Ana Liffey Drug Project has recently
expanded its peripatetic needle and syringe programme (NSP)
as part of a progressive form of innovative outreach work. The
2013 version of the project, which was originally launched in
June 2010, combines old-fashioned footwork with
telecommunications, emerging technologies and high-visibility
promotional material on the streets. 
The project was brought to my attention during a recent visit to the Republic of
Ireland and I was fascinated by the initiative because of its relevance to topics that I
have spent almost six years researching in various towns and cities throughout the
UK – namely street-based injecting and drug-related litter. I was so impressed by the
project that, on my return to England, I contacted the director of the Ana Liffey Drug
Project, Tony Duffin, to find out more about this potentially groundbreaking venture.
Ana Liffey Drug Project is
a national addiction service
with a low threshold harm
reduction ethos. The
organisation receives funding
from a number of sources,
including the Health Service Executive, drug and alcohol task forces, the
Probation Service of Ireland, other local authorities and government
departments. One of the ways Ana Liffey engages with drug users and other
stakeholders is in the reduction of drug-related harm associated with episodes
of street-based injecting, which often takes place in public places throughout
Dublin city. As an indicator of the frequency of public injecting in the city
centre, a recent report (Re-establishing contact: A profile of clients attending the
health promotion unit – needle exchange at Merchants Quay Ireland) highlighted
that 14 per cent of the 388 injecting drug users attending a fixed-site city
centre NSP reported regular injecting in public places ‘in the last month’. This
translates to approximately 55 individuals of the cohort regularly involved in
episodes of street-based injecting in concealed alleyways and side streets
throughout the city. 
Furthermore, as there are few public conveniences in
Dublin city, street-based injecting sites are located in
what I have termed category B and category C settings,
such as alleyways, doorways and secluded settings
hidden from public view, or in ‘opportunistic’ settings
concealed within business premises. These are places
that are among the most harmful environments for
street-based injecting drug use. For these reasons, Tony
Duffin made the case for introducing medically
supervised injecting centres to Dublin at a recent safer
city for all seminar (http://www.aldp.ie/resources/video).
In the meantime, the Ana Liffey Drug Project is
continuing to provide a proactive outreach service as
part of an ongoing harm reduction response to street-
based injecting drug use. This involves two outreach
workers walking the streets of central Dublin equipped
with, among other things, a pink vanity case for carrying-
out street-based interventions. The case makes it easy
for clients to locate the staff, who often deliver the
service in busy city centre locations. Within it is a range
of injecting equipment and other paraphernalia that
would be available from a more orthodox (static) NSP. As
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Stephen Parkin was so impressed
by The Ana Liffey Project’s innovative
street-based outreach work in Dublin
that he contacted director Tony Duffin
to find out more
Getting
streetw
‘All our staff are very client
focused, we’re constantly
seeking new ways to reach
marginalised clients, or to
improve accessibility to
existing services...’
such, water-amps, swabs, filters, steri-cups and a range of needles (including
Exchange Supplies’ ‘NeverShare’ variety) and barrels can be provided, along with
harm reduction brief interventions. Each NSP pack given out also has an
adhesive label on it that promotes safer disposal with the peer-designed slogan,
‘If You Bang it, Bin It!’ – itself an illustration of dynamic, creative and innovative
outreach work that challenges many drug-related outreach projects’ reluctance to
walk the streets with injecting equipment for wider distribution. 
Dotted around the city centre on many of the public litter bins are dedicated
advertising slots that have been provided by Dublin City Council at no cost to the
Ana Liffey Drug Project. Duffin explained that these prime advertising sites
provide the ideal opportunity to publicise and promote the project’s outreach
work, and its 1800-78-68-28 Freephone line gives callers information and
signposting to services.
Staff at Ana Liffey have combined the telephone service with the
outreach service to create a genuinely innovative and rapid
response NSP throughout the city centre. As Duffin says, ‘All our
staff are very client focused – we’re constantly seeking new ways to
reach marginalised clients, or to improve accessibility to existing
services.’ In the case of the NSP, individuals may call the 1800
number free of charge and be transferred to an outreach worker’s
mobile phone. The client and workers arrange a mutually
convenient time and location to meet, giving an opportunity to
discuss injecting paraphernalia and how the client can obtain new
equipment and return used paraphernalia. They are also offered
sharps boxes in an attempt to minimise drug-related littering. As
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with conventional NSP, this meeting also provides opportunities to conduct some
form of limited intervention, such as checking an individual’s physical injecting
sites and inspecting any related injuries, and providing a referral to the blood
borne virus nurse at Ana Liffey’s medical surgery.
Provision of equipment takes place in a discrete manner and does not involve
the open distribution of injecting equipment for all to see. As with conventional
NSP, activity data is collected by the outreach team, including documenting the
interaction and what items may have been distributed and returned. In the first
five months of this year, 381 NSP interventions were done under this system of
outreach, including telephone referrals. 
Further developments in this street-based project are to pilot the use of a
tablet, or other portable device, that can be linked to a centralised system for
recording similar data within static sites of NSP and have the ability to show
harm reduction videos relating to safer injecting. This would help to feed live data
to a master-monitoring system and provide immediate up-to-date information
regarding process, performance and outcome of all relevant activity. Ana Liffey
also intends to promote its Freephone number across the 12 counties of Ireland
where they currently provide direct client services through a telecommunications
hub, linking Freephone callers throughout Ireland to satellite Ana Liffey outreach
teams that can best respond to the caller’s needs.
This street-based form of NSP is innovative because, as far as I am aware, it
is the only service where the caller is directed by internal transfer within the
offices of a central location to an outreach team’s mobile phone. However, what
struck me most about Ana Liffey’s outreach project is the pioneering and
inventive application of old and new methods – combining peer-based outreach
with portable telecommunications that in turn are advertised by traditional
methods using street-based furnishings (litter bins). As the latter are positioned
in street settings they are more likely to be noticed by the target population of
this particular project – people who are homeless and/or those participating in
street-based injecting. 
Simplicity and technology underpin the initiative to provide a method of actively
engaging with street-involved individuals who may not necessarily be in contact
with mainstream drug services. I am further impressed by how the project
genuinely reflects the original street-based ethos that defined harm reduction
throughout the UK during the 1980s.
In terms of drug-related outreach work, however, the project ticks all the
required boxes. In addition to engaging with hard-to-reach populations, it also
involves participation, intervention, advice and information, and creates
opportunities for referral to other services
while complying with the need for
confidentiality. In short, it is a project that
is consistent with the practice and
principles of harm reduction, and its
street-based focus provides culturally
relevant and environmentally significant
opportunities for interaction and
communication.
Indeed, this is a project that should be
given some consideration in other settings
and could very easily be emulated
throughout the UK and beyond, made
easier by Ana Liffey’s culture of sharing
their resources, knowledge and expertise
as much as possible.  DDN
Stephen Parkin is a research fellow at
the University of Huddersfield and is the
author of Habitus and drug using
environments (published by Ashgate
Sociology, 2013). Email:
s.parkin@hud.ac.uk
Tony Duffin is director of the Ana Liffey
Drug Project. Further details of the street
work described above are available from
tony.duffin@aldp.ie
Getting
streetwise
We welcome your letters...
Please email them to the editor, claire@cjwellings.com or post them 
to the address on page 3. Letters may be edited for space or clarity –
please limit submissions to 350 words.
Post-its | Letters
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LETTERS
FALSE DICHOTOMY
In her open letter to Anna Soubry MP
(DDN, July, page 8) Dr Chris Ford draws
an erroneous and largely unhelpful
distinction between treating drug
misuse as a health issue and treating
it as a criminal justice issue. 
In peer-reviewed research evaluating
the impact of major drug enforcement
operations on street-level drug markets it
was found that the proportion of drug
users contacting a methadone prescribing
clinic increased massively from 30.2 per
cent in the weeks in advance of the
operations to 84.3 per cent in the weeks
following the police operations
(McGallagly and McKeganey 2012). 
This research shows that drug
enforcement operations can have a
welcome positive impact on
encouraging drug users into drug
treatment. Instead of claiming that drug
use is either a health or a criminal
justice issue we need effective joint
working between health and criminal
justice agencies and a recognition that
both domains have an equally
important contribution to make in
tackling drug misuse.
Ref: McGallagly, J., McKeganey, N.
(2013) Does robust drug enforcement
lead to an increase in drug users?
Drugs: Education, Prevention, and Policy,
2013, Vol. 20, No. 1: Pages 1-4.
Neil McKeganey Ph.D, director, Centre
for Drug Misuse Research, Glasgow
SELF-HELP SALVATION
It is ridiculous for Ford and Soubry to
be battling it out over whether addiction
is a criminal or a health issue. It is the
failure of the law and of medicine to
understand and cure addiction that
gives neither of them the right to even
have an opinion.
Addiction is simply a current
condition initiated by an individual
making the mistake of choosing to use
an addictive substance in an attempt to
solve a ‘personal’ problem. It is
straightforwardly a personal decision,
made alone or in agreement with
advice, which proves to be a mistake,
and for which medical ‘treatment’ has
never been an answer. Nor, as history
shows, can criminal punishment resolve
the country’s addiction problems.
When the coalition chose as the first
strand of their 2010 drug strategy
‘reducing demand’, they knew what they
were doing, because they were focusing
on the source of our addiction problems
– the individual addict. As they move
towards ‘localism’ they are again
focusing on the individual addicts that all
inevitably exist in their local community.
It follows that reducing demand is
achieved solely and only by curing
individual addicts, and this is just not
occurring other than sporadically as a
result of medical treatment or criminal
labelling or trying to restrict supply.
But it can be achieved by recognising
that life is a do-it-for-yourself activity,
that deciding to use drugs is also a do-
it-for-yourself activity and that quitting
addiction is most often achieved on a
self-help basis.
Seventy to 75 per cent of addicts
who have used for three days, three
weeks, three months, three years or 30
years have tried, often daily, to quit and
have failed – but still want to quit.
All they lack is the knowledge of how
to attain lasting relaxed abstinence, and
we know from the results of addiction
recovery training delivered since 1966,
and now at 169 centres (including prison
units) in 49 countries, that 70-plus per
cent can cure themselves.
So lets give addicts and the drug
strategy a chance – by training drunks
and addicts to cure themselves.
Kenneth Eckersley, CEO, Addiction
Recovery Training Services (ARTS)
35 YEARS STRONG
Norwich charity NORCAS are celebrating
35 years of working in the region with a
huge birthday party – all welcome! 
Since 1978 when NORCAS opened
its first alcohol service in Norwich they
have gone on to provide drug, gambling
and welfare rights services for many
thousands of people across East Anglia.
Now working in partnership with national
substance misuse charity Phoenix
Futures under the name Phoenix +
NORCAS, the party will be an opportunity
to hear inspirational stories of recovery,
meet staff, volunteers and service
users, past and present and to learn
more about the plans for the future. 
The party to be held on 22 August
at OPEN, 20 Bank Plain, Norwich NR2
‘The proportion of drug
users contacting a
methadone pre scribing
clinic increased massively
from 30.2 per cent in the
weeks in advance of the
operations to 84.3 per cent
in the weeks following...
police operations.’
Skills for Health is undertaking a review of the National Occupational
Standards (NOS) for specialist workers who work with adult substance users.
The NOS, first developed with stakeholders in 2005, are being reviewed
by a working group consisting of service user organisations and stakeholders
who work in substance use services. A steering group is overseeing the
project, consisting of members from the four UK nation government
departments and chaired by Carole Sharma, chief executive of the Federation
of Drug and Alcohol Professionals (FDAP). ‘Stakeholders will welcome the
review of the NOS for the substance misuse sector as it is vital that the
standards reflect what workers are currently doing as part of their practice,’
she says.
This review is to ensure that the NOS reflect up-to-date practice in the
field of substance use and that workers who wish to use the NOS are
working to a set of defined standards. The project working group includes
members from the four UK nations, and the revised NOS will reflect common
practice right across them. 
The drug and alcohol NOS, commonly known as DANOS are widely used
across the health, care and justice sectors. NOS can be used for a variety of
purposes, all of which lead to the development of a particular workforce.
The DANOS have been used to underpin nationally accredited qualifications,
such as:
• the level 3 diploma in health and social care and level 3 SVQ in
health and social care, which assess competence against the NOS
• the level 3 and level 4 awards and certificates in working with
substance misuse.
They are also used:
• to develop new roles for the sector
• in frameworks for staff development 
• to improve standards of practice across the sector by organisations
such as FDAP
• to develop a variety of bespoke training and education programmes. 
The working group, chaired by John Jolly of Blenheim CDP, has been working
to update the standards and they will be available for consultation until 30
September 2013. A consultation for service users will also be available and
their responses will inform the final content of the updated NOS. This
consultation will run until 12 September 2013.
Once final versions of the NOS have been approved by the UK
Commission for Employment and Skills, they will be accessible via the Skills
for Health competence tools.
For further information about both the service user and NOS consultations
and the Skills for Health tools, visit the Skills for Health website
www.skillsforhealth.org.uk or email danos@skillsforhealth.org.uk 
Skills for Health is the sector skills council for all health employers – NHS,
independent and third sector – and acts as the voice for employers working in
the healthcare sector.
Nadine Singh is manager of NOS, qualifications, apprenticeships, products
and services at Skills for Health
SKILLS UPDATE
What’s the latest on
professional training?
Nadine Singh explains
the DANOS review
REVIEW
Letters | Skills for Health
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4SF, between 10.30am and 3.00pm,
is open to all who want to drop in.
Lunch and (of course birthday cake!)
will be provided.
As Paul Hammond, Phoenix and
NORCAS service manager says, ‘Over
the last year alone NORCAS has
worked with 8,342 adult and youth
clients across Norfolk and Suffolk, and
positively impacted the lives of many
more through educational events. We
want to thank the local community for
the support they’ve provided us to
help so many local people make
positive changes in their lives.’
For more information go to
www.phoenix-futures.org.uk/phoenix-
norcas/ or contact me on
bob.campbell@phoenix-futures.org.uk 
Bob Campbell, special projects
officer, Phoenix Futures
HELP THE AGED
I have been trying to raise the profile
of alcohol misuse in older people for
some years, particularly as my own
clinical service covers a population
that has a rate of alcohol-related
deaths in the 75-plus age group that is
more than twice the national average. 
Older people with alcohol problems
remain caught between services.
Luckily for me, I managed to gain
additional skills in substance misuse
and integrate these into a mainstream
mental health of older adults service. 
I would be interested to know
whether practitioners see this as a
growing clinical and public health
problem and what is being done to
tackle this problem in their local
area or region.
Dr Tony Rao, consultant old age
psychiatrist and chair of Royal
College of Psychiatrists Substance
Misuse Working Group
HOW LUCKY WE ARE
Reading the coverage of the
International Harm Reduction
Conference really brought it home
how lucky we are in the UK (DDN,
July issue). 
Sadly I was unable to attend in
person but by reading the DDN Daily
updates and the special issue I was
able to get a real sense of the
genuinely life-threatening situations
that users in many countries face. It
once again reinforced the indisputable
fact that harm reduction saves lives. 
To have the luxury of debating the
individual nature of recovery and
patient choice is something that
many of the speakers at the
conference must dream about, and
we would do well to remember that.
While the stories of the ongoing
battle to have their drug use
recognised as a health issue, and the
ongoing human rights abuses were
as harrowing as ever, there did seem
some cause for cautious optimism. 
The, albeit slowly, changing
political acceptance that harm
reduction works, the increasing high-
profile support and, most importantly,
the untiring work of the activists
working across the world do give you
hope that things will get better. I
would like to thank both Harm
Reduction International for having the
courage to hold this unique event,
and DDN for providing coverage to
everyone unable to attend.
J Spence, by email
DDN provided daily magazines 
for the International Harm
Reduction Conference 2013 in
Vilnius. These and the August 
DDN coverage can be read at
www.drinkanddrugsnews.com.
IN PRINT, ONLINE, 
VIA EMAIL AND
SOCIAL MEDIA
We have been working extremely hard
over the last few weeks on
www.drinkanddrugsnews.com.
The website has always reflected the
publication, with every issue of DDN
available to read free-of-charge in both
PDF and mobile formats, as well as up-
to-date news, jobs and tenders. The
website also provides links to other
sites, training and rehab directories
and all back issues of DDN available as
a searchable archive. In addition,
updates and breaking news are
available on our Facebook page and
through our Twitter feed. We have
always provided a weekly DDN email
letter but this is now in an improved
format and easily readable on
computers, tablets and smartphones.
Subscribing couldn't be easier – simply
enter your email on the DDN home
page and you’ll get the latest issue
straight to your inbox!
Follow DDN online:
Facebook: DDNMagazine 
Twitter: @ddnmagazine 
Subscribe via email at
www.drinkanddrugsnews.com 
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The challenge of not losing sight of
the individual in the new public
health landscape was one of the
themes discussed at a recent event
organ ised by the London Drug and
Alcohol Policy Forum. DDN reports
have to move much more in that direction because we’re going to have to make
the most of the resources we’ve got in the community. 
‘The key thing is to stop bringing people into services,’ said the organisation’s
recovery and tier 4 lead, Brian Hindmarch. ‘Take the services into the community.’ 
One of the biggest problems facing treatment was translating its founding
vision across the workforce and to partner organisations, said Counted 4’s
medical director, Dr Martin Weatherhead. ‘We can often say, “for this group of
people we provide a fabulous service”, but I’ve not really come across a system
that provides that across the board.’
While there had been no major change in the evidence base, there had been
changes in the interpretation of that evidence base, he continued. ‘What we’re
guilty of is extrapolation – there have been changes in emphasis, but no huge
changes in fact.’
Keyworking was vital, he told the event. ‘Prescribing is just a little bit of oil in
the engine of treatment – you can’t build everything around that. The medication
hasn’t changed, the facts haven’t changed, but everyone’s now terrified of being
seen as “parking” people on methadone. But there are people who need those
higher doses. We’re moving back into a more regimented treatment world, and that
does concern me.’ 
One problem that treatment needed to overcome was that NICE guidelines
were constantly employed as obstacles, said one delegate. ‘If they don’t want to
do something, or if they do, then you hear, “ah, it’s the guidelines”.’
‘As an industry, our customers aren’t our first priority,’ said another participant.
‘The drug treatment system has been awash with money for years, but no one
ever says that everything’s working well.’ However it was impossible to commission
‘perfectly individualised’ services for everyone, replied another. ‘It’s a pipe dream.
What you can do is get what’s best for that individual at that time, because it
changes over time – people change, systems change, money flows change. You
need flexible services that are responsive. A lot of it is about relationship
management and being human – it’s a patchwork.’ 
While the recovery agenda contained a great deal of pros and cons, ‘one
positive thing to come out of it is to try to get the best for your clients,’
commented another delegate. ‘But changing the ethos of an organisation can be
like turning a tanker.’
‘Get to know the client,’ stressed one participant. ‘On paper they may look like
one thing, but you need to get to know them. And continuity is vital.’ Having the
right people with the correct skills set was vital, added another. ‘The right person
for the right role.’ 
An obvious problem facing the sector was that budgets were no longer ring-
fenced, a delegate stressed. ‘So we need to show that the things we commission
A Vision to 
‘W
e were created as a response to what was a frankly
appalling drug and alcohol treatment system in Sunderland,’
CEO of Counted 4, John Devitt, told delegates at the London
Drug and Alcohol Policy Forum’s recent Our friends in the
north event. ‘There were six- to nine-month waiting lists and
very rigid prescribing regimes. We were set up to serve the people of Sunderland
– it’s about treating people in the community in the normal way, without
ghettoising them.’
A clinically led organisation and community interest company (CIC), Counted
4 employed doctors, nurses and drug workers, and provided a range of services
in the home. It also tried to work in partnership with key providers, such as
pharmacies, he said, and aimed to be client-focused, non-judgmental, accessible
and community-based. 
‘We’re living in a very interesting world – it’s a time of huge social change,’
he said, with welfare reform, funding cuts and the move to Public Health England
all having an impact. While there had been positive changes – such as the focus
on recovery – the poor were now being widely demonised, he stressed, which
was having a profound effect on vulnerable people. 
Treatment staff were also worried about their job security, he said. ‘But the
real question is who’s worrying about the clients? It’s also a unique situation in
that the main political parties seem to agree on pretty much everything when it
comes to these changes, and many charities are just toeing the line. Everybody
talks about working in partnership, but partnership is about sharing an ethos,
sharing working practices, sharing the good and bad times. Everyone’s going to
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are meeting what they’re supposed to. Ultimately it comes down to whether
we’ll continue to be funded – and if the service is cut, that doesn’t meet
anyone’s needs’, while others commented that disinvestment was already
happening. 
There were also significant problems around recruiting specialist GPs,
Martin Weatherhead told the event. ‘The areas where you have the most
problems recruiting doctors are deprived areas. Doctors are herd animals –
they’ll go where the herd is grazing. There’s a huge recruitment crisis in
general practice – the GPs who are working are overwhelmed and the last
thing they want to do is make their lives even more difficult by working with
people with substance problems.’
Risk was often used as an excuse not to act, commented one delegate.
‘Senior politicians need to have the ability to trust people to deliver, so they
can prove the impact. You’ve got to protect your funding streams, but there’s
no trust that things will actually be delivered. There’s got to be a better way
than just telling us to tick boxes.’ 
‘You have to bring hope and aspiration into it,’ said John Devitt. ‘If you can’t
do that – because you’ve had a crap day or whatever – then you’re messing with
people’s lives and you shouldn’t be in this profession. We’re defining people by
their symptoms, so you’re not designing the system for individuals. The key is
personalisation – you’re providing a service here. It’s a privilege to be looking
after these clients, and if you really believe that you’ll get the results.’  DDN
  serVe
‘The key thing is to
stop bringing people
into services... 
Take the services 
into the community.’ 
BRIAN HINDMARCH
ENTERPRISE CORNER
A TALE OF TWO
ENTREPRENEURS
Nola and Jackie are living proof that you can
turn life’s adversities into business opportunities,
says Amar Lodhia
OUR VISION STATEMENT GUIDES OUR WORK:
‘Our vision is to create an enterprising and
entrepreneurial society that does not hold
people back from becoming successful.’ 
When you hear from people like Nola and
Jackie you feel that we all can bridge the gap
between aspiration and inspiration and you
reiterate the fact that we all can make an
impact and a difference in people’s lives. Lest I
bore you with my motivational talk, let me
delve more into the real stars of this tale, Nola
and Jackie – two of the participants from our
City of London E=MC2 programme.
When Nola left prison, she came back home and looked for a job to no
avail, but since she joined the TSBC programme she has started her own
business, an initiative to get ex-offenders into work, called ‘Wanna work’. 
When Nola completed her prison sentence, she came back home and
looked for a job to no avail. She believed she was being stereotyped by
employers because of her past criminal history, then thought: ‘I have
served my time and I am a better person but why does society want to hold
me back?’ 
In her new life chapter, TSBC’s E=MC2 programme has inspired her to
start her own community interest initiative for those who have left prison
and are searching for work. ‘I think the course is excellent, well delivered
and practical learning models were used,’ she said. ‘I have been able to put
my ideas into practice and make steps towards starting my own business.’
We see a serial entrepreneur in the making, as Nola has several other
start-ups in the pipeline, including an organic food catering business. 
Jackie had been unemployed for years after she had finished serving her
probation and was on benefits. However unhappy, she continued teaching
drama classes to children, although she knew she had more to offer society. 
She was invited to the TSBC E=MC2 programme by a friend and it
created a world of hope and opportunities for her. She has started her baby
clothing business and has stopped collecting benefits. ‘I enjoyed the fact
that E=MC2 helped me to push myself a lot and gain more business skills,’
she said. 
Jackie’s future is filled with aspiration and hope. She now feels
independent and in control of her future, and is not dependent on
government benefits or even employment anymore. She is very excited
about her baby clothing manufacturing business. She has her business
plan, design prototype and the support of her TSBC mentor, and is ready to
take on the world.
To enquire more about our work please contact me at ceo@tsbccic.org.uk
and follow me on Twitter @amarlodhia or @tsbclondon – don’t forget to use
the #tag DDNews when tweeting!
Amar Lodhia is chief executive of The Small Business Consultancy CIC
(TSBC), thesmallbusinessconsultancy.co.uk
Tobacco | Harm reduction
If electronic cigarettes can
save lives, why are we
jeopardising this public
health breakthrough, 
asks Professor Gerry Stimson
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Until recently, an end to cigarette smoking
looked like a long and slow business. Year on year only small reductions
have been made in reducing smoking prevalence in developed countries.
The arrival of electronic cigarettes (e-cigarettes) and other new
nicotine delivery devices changes that. These new devices are a
disruptive technology, just as the invention of the cigarette-making
machine was in the 1880s. There are now real prospects of helping
smokers shift from smoking tobacco to using nicotine by less
harmful routes. 
The Medicines and Healthcare Products Regulatory Agency
(MHRA) and the European Commission (EC) now want to regulate
e-cigarettes as medicines. Will this advance the sale of e-
cigarettes, or push back the progress that has been made?
First introduced to the UK in 2006, uptake of e-cigarettes
has been a relatively quiet consumer-led revolution. There
has been no public health input or encouragement, and no
spending of NHS resources – no taxpayers have been harmed in
this process. There has been little expenditure on marketing. The growth in
popularity has come about by word of mouth and internet advertising. Unlike
many public health measures, there is a population ready and eager to change –
most smokers want to stop smoking. Until e-cigarettes there was no viable option
but to quit smoking altogether or to use nicotine replacement therapy (NRT). 
The MHRA estimates that 1.3m people are using e-cigarettes in 2013. The
proportion of smokers using them rose from 3 per cent in 2010 to 11 per cent in
2013. The European market is estimated at around EUR 400-500m, and sales of e-
cigarettes now equal those of NRT. The market has been dominated by mainly
small and medium-sized distributors, but this will change as most major tobacco
companies are already selling or investing in the development of new nicotine
delivery devices.
Most anti-smoking organisations aim for an end of the tobacco industry.
Ironically – for many public health experts – an end to tobacco smoking may be
hastened not though the end of the tobacco industry but through its
transformation. In the next couple of decades, tobacco companies, under pressure
from anti-tobacco legislation, will move towards becoming nicotine companies.
Wells Fargo stock analysts predict that revenue from e-cigarettes will overtake
ordinary cigarettes by 2021.
E-cigarettes v smoking tobacco
E-cigarettes have major advantages over smoking tobacco. More than 4,000
chemical compounds are found in tobacco smoke, and it’s the products of the
burnt organic material that are so harmful to health. Around 80,000 people in
England die every year from smoking-related disease. Smoking is the single most
common cause of preventable illness and death. As Mike Russell noted long ago,
people smoke cigarettes for the nicotine but die from the tars. 
E-cigarettes contain nicotine, propylene glycol (a carrier that creates the
vapour when heated) and flavourings. They deliver nicotine but without the
dangerous toxins found when tobacco is burnt. They are used by people who
want to stop smoking but who do not want to or cannot stop using nicotine. 
A visit to e-cigarettes and vaping websites indicates extraordinary testimony
of their successful use by long-term smokers. E-cigarettes contain some
potentially harmful constituents but at traces very much lower than found in
regular cigarettes, within the safe limits for consumer products, and indeed at
similar levels to potentially harmful constituents found in NRT. And their
attraction for many users is precisely that they are not medicines.
A CASE F
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Where to with tobacco policy?
Harm reduction is central to current tobacco policy in England. This will be
welcome news to those in the drugs field who feel rather beleaguered and
browbeaten by the drugs recovery agenda. 
The history of tobacco harm reduction is tied in with the development of NRT. In
1990 there were only three NRT products, all prescription-only. Pharmacy sales
started in 1991, expanded to all products by 2000, and since 2009 all NRT products
have been on general sale. Initially NRT was only indicated for abrupt quitting, and
later extended for people who wanted to cut down more gradually before stopping.
But in 2009/2010 the MHRA agreed it could be used for harm reduction, including
temporary abstinence and a reduction in smoking with no intention to quit.
The Department of Health’s 2011 tobacco control plan committed to
encouraging tobacco users who cannot quit to switch to safer sources of nicotine
and to encourage manufacturers of safer sources of nicotine to develop new types
of nicotine products. In 2012 the Cabinet Office’s behavioural insights team – the
so-called ‘nudge unit’ – urged the use of e-cigarettes. 
The most recent piece of the story is the work of the National Institute for Health
and Clinical Excellence (NICE) which gives a strong endorsement for tobacco harm
reduction for people who do not wish to quit smoking altogether, and for people
who want to quit smoking but are unable or unwilling to quit using nicotine. The
NICE group concluded that nicotine does not pose a significant health risk.
Enter MHRA and the European Tobacco Products Directive. The MHRA has
decided to regulate all electronic cigarettes as medicinal products by 2016, and
the European Tobacco Products Directive – currently going through the European
legislative process – proposes that all e-cigarettes should be regulated under
medicines legislation. 
‘Smoking cessation’ or ‘smoking sensation’?
Those in favour of medical regulation argue that electronic cigarettes are currently
unregulated products, that they are accessible to children, that there is no control
over advertising, that they contain potentially dangerous constituents, and that the
devices themselves, including the batteries, pose a threat to user safety. 
Medicines regulation, they argue, will improve safety, quality and efficacy, and
make them work better as a smoking cessation product.
There is another thread going through the political argument however, which
is that electronic cigarettes are just another way to feed addiction to nicotine, and
that they send the wrong message and undermine attempts to drive down
tobacco use. Some claim that electronic cigarettes are contrary to efforts to ‘de-
normalise’ smoking. There are already scaremongering stories about
schoolchildren using them. Certainly they might be a short-term fad amongst
some children who wish to challenge authority, but the e-cigarettes market is
made up of long-term smokers and surveys by Action on Smoking and Health
(ASH) show minimal use by non-smokers and by young people. 
Consumers do not want medical regulation. There has been extensive
comment on the proposals on social media sites, Twitter, and letters to members
of the European Parliament – current users insist that these are consumer
products, a safe way of enjoying nicotine, rather than a therapy. These products are
popular precisely because they are not medicines. As one user put it – these are
not ‘smoking cessation products’, they are ‘smoking sensation products’.
Getting the balance right
The problem is the trade-off between making the product safe enough, but also
sufficiently attractive to achieve widespread uptake. On balance more weight
should be given to attractiveness, given their relatively low risks and the huge
consequences of continued smoking.
The argument that these products are currently unregulated is false. The
Electronic Cigarette Industry Trade Association has shown that they are covered
by the General Product Safety Directive and various other EC directives covering
electrical safety, chemical safety, weights and measures, packaging and labelling,
commercial selling practice and data protection. 
Applications to MHRA are costly, including the licence fee and the required
studies, analyses, documentation. There are fears that few companies will be able
to afford this, that
the process will
favour big players and
drive many products
off the market. There
are further problems
with medical
regulation in that e-
cigarettes include a
big range of products
and product
combinations. Not all
of them are simple
pre-packaged
cigarette lookalikes,
but many are customisable, where the user can vary the delivery device and the
nicotine strength and flavourings. It is likely that medical regulation will
prematurely limit the range of products and stifle innovation. 
Even the announcement of future medical regulation has created uncertainty
among retailers, current and potential e-cigarettes users.
How this will play out is uncertain. Given that MHRA has put the deadline as
2016, by then there will be a much larger market and it will be harder to limit and
control products. Already there have been four successful legal challenges against
classing these products as medical products (two in Germany, and one each in
Estonia and the Netherlands). 
At the end of the day the potential public health gains from e-cigarettes will
be determined by the decisions about how to regulate these devices. There is
right thinking about tobacco harm reduction, but a risk of making significant
mistakes in the way this is played out in regulatory frameworks. 
The danger is a classic regulatory trap: making safer products harder to obtain
than their unsafe counterparts. The regulatory proposals are tougher on e-
cigarettes than on tobacco cigarettes. The framing of electronic cigarettes within
a regulatory context misses the point that the public health drive must be to
promote, endorse and facilitate their use.  DDN
Prof Gerry Stimson is visiting professor, London School of Hygiene and Tropical
Medicine and director of Knowledge-Action-Change.
 FOR E-CIGARETTES
Green ZONE
Green Party MP for Brighton
Pavilion Caroline Lucas tells 
David Gilliver why she wants the
government to acknowledge that
‘current policy is flawed’
‘As an MP for a city with such high levels of drug-related harm, it would be
negligent of me not to ask whether we could be doing things differently,’ says
Caroline Lucas. ‘As well as identifying the national policies that get in the way.’  
A member of the Green Party since 1986, she became one of the party’s first
MEPs in 1999 and was made party leader in 2008, before being elected the UK’s
first ever Green MP – ‘a privilege’, she says – for the constituency of Brighton
Pavilion in 2010. 
She’s currently enthused about a Private Members’ Bill she’s about to present
calling for the railways to brought back into public hands as franchises expire –
‘potentially saving the Treasury more than a billion pounds a year’, she says – but
she’s long been interested in drug policy as well, sparked by a sense of injustice at
seeing people ‘pointlessly criminalised’ and by frustration at what she considers
to be doomed policies. ‘On an intellectual level it’s clear that current policies are
failing,’ she says. ‘But I’ve also seen first-hand the terrible effects that’s having.’
Brighton is famous for many things, but the grimmest was always the
number of drug-related fatalities in the city, earning it an unenviable reputation
as ‘drug-death capital of the UK’. Recent signs are encouraging, however. From
50 drug-related deaths in 2009, the number fell to 35 the following year, and,
according to the Independent drugs commission for Brighton & Hove report from
earlier this year (DDN, May, page 5), the indications are that ‘the trend is being
continued through 2011 and 2012’.
Problem drug use is still clearly a major issue in the city, but does she think
it’s fair to say that the situation is improving? ‘Levels of drug-related harm and
deaths in Brighton and Hove are still worryingly high, but good progress is
being made,’ she says. ‘In the last few years we’ve seen, for example, a 17 per
cent increase in numbers of people leaving treatment successfully, compared to
the 7 per cent national average.’
Some of these improvements can be attributed to ‘different approaches
being taken locally, in particular through intelligent commissioning,’ she says.
‘And we are saving more lives thanks to initiatives like making naloxone more
widely available.’
In terms of different approaches taken locally, while the Brighton and Hove
drug commission’s report included 20 recommendations – among them increased
training in naloxone administration, better data collection on drug use trends and
improving services for those with a dual diagnosis – the one the national media
inevitably seized on was the call to establish consumption rooms. Or rather, to
quote the actual wording of the document, to ‘convene a working group to
explore the feasibility of implementing a form of consumption room, targeting
those who are hard to reach and not engaged in treatment, as part of the range
of drug services in the city’.
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Does she find that a frustration – are the press dictating the terms of the
debate? ‘It would have been great for all of the drugs commission’s
recommendations to have received the attention they deserved, but the press
stories were always going to be about drug consumption rooms, and that at
least put the report in the public eye,’ she states. ‘But I do think some of the
popular press make it very difficult to have a nuanced debate about drugs
policy. It’s clear that mainstream politicians won’t go near certain solutions – no
matter how evidence-based they are – because they’re worried about the
headlines in the Daily Mail.’
Nonetheless, decriminalisation is an increasingly mainstream topic of
discussion in the media these days, something that was unthinkable a few
years ago. ‘We’re not there yet – the immediate goal is the impact assessment,’
she says, referring to the call for a comprehensive review of the 1971 Misuse of
Drugs Act (DDN, June 2011, page 5). According to the petition she’s created on
the government’s e-petition website, ‘nobody is checking whether Britain's
current approach is value for money or money wasted’.
It’s primarily about ‘getting the government to at least acknowledge that
current policy is flawed,’ she stresses. ‘However, I don’t think decriminalisation
in the future is out of the question, by any means. Some societies that you
might think of as socially conservative – Portugal and Switzerland, for example
– have introduced decriminalisation, or other policies based on health not
crime, and seen positive results. If you believe in evidence-based policy-making
and want to reduce drug-related harm, this is the logical first step.’
*****
She recently coordinated an open letter to the Timeswhich, along with urging the
government to agree to an independent review of the Act, exhorted the coalition
to join ‘the global effort towards an alternative strategy based on evidence’. How
confident is she that messages like that are going to be taken on board?
‘I’d like to think that there’s a point at which ministers have to change
course, just because the evidence is so compelling,’ she states. ‘But it’s difficult
to say when. Certainly we’re making the case very strongly, and in terms that
should appeal to ministers – our arguments are all about reducing the harms
caused by drug addiction and using taxpayers’ money more effectively.’
On that note, does she feel that moving drug and alcohol treatment to local
authorities, overseen by Public Health England, was the right thing to do? ‘It’s
vital that everyone gets the drug and alcohol treatment they need,’ she says. ‘I
think this is undermined by the fragmentation of the NHS, and there’s a risk
that services will be poorly integrated and people will fall between the gaps. I
just hope that – as in Brighton and Hove – local authorities will continue to
make drug and health services a priority.’
The UN’s International Day against Drug Abuse and Illicit Trafficking on 26
June saw her donning a Richard Nixon mask outside the Houses of Parliament
(DDN, July, page 4), as one of those protesting to ‘reclaim’ the date as part of
the Support. Don’t Punish day of action. What made her decide to back the
campaign? 
‘Because the whole “war on drugs” approach is colossally damaging,’ she says.
‘It has meant the mass imprisonment of people who use drugs. It has allowed the
international trade in illegal drugs to thrive. And, after decades, it has completely
failed to reduce drug-related harm. Governments need to adopt approaches
based on evidence, which deal with addiction as a health issue.’ DDN
‘I’d like to think that
there’s a point at which
ministers have to change
course, just because the
evidence is so compelling.’
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IT HAD BEEN A CHOICE BETWEEN PRISON OR DETOX AND TREATMENT. 
I took detox and treatment. After a while prison began to seem like the choice
I should have made: I had a drug counsellor who was constantly getting in my
face and I had to sit in circles with idiots talking about ‘feelings’. I hadn’t had a
feeling much other than sick or numb for years, let alone have a discussion
about them. The only thing that kept me there was that my drug counsellor
was like me; Scottish, feisty and had been a junkie and criminal.
They made me go to 12-step meetings. I had been detoxed from alcohol
and drugs and four months later I was at one of these 12-step conventions.
There were hundreds of addicts like me, but they looked happy – I couldn’t
understand what they had to be happy about. Then I heard a woman talking
on stage. It was the same as all the others – took drugs, got bad, got clean. I
was zoning out. 
Then she said something that woke me up: ‘In recovery, I got tested and
was diagnosed with HIV’. She stopped what she was saying and started crying.
She broke down on the stage, in front of everyone. I was embarrassed for her.
Then somebody behind me shouted ‘we love you’. Then another, and another
– until the entire hall of addicts were shouting and whooping and clapping. 
That’s when it hit me. This is where I am meant to be. All those years, all
those scams, all those drugs – all I wanted was this. I wanted to belong. 
It wasn’t all plain sailing after that. Detoxing was the easy part. I was 32
and had no idea how to live like normal people. Everything, from making a cup
of tea to getting a part-time job, was a first without drugs. Slowly, one day at
a time, I learnt how to live without a drink or a drug. I was able to make
amends to the people I had hurt. I was able to look my dad in the eye and
make peace with him before he died. I was able to be a son to my mum again. 
Seven years after getting on my knees and begging for help in St Thomas’s
toilet, I found myself in the same cubicle after the birth of my son. I looked at
my reflection in the mirror and compared my happiness and joy with the
despair and dereliction of myself seven years before. I started to cry. This time
they were tears of gratitude. I was alive and I was happy. 
It’s been 16 years since I went into that detox. In that time I’ve made some
mistakes, but I’ve never picked up a drink or a drug. I’ve got two beautiful
children, a loving girlfriend and my own counselling practice in Harley Street.
Most of all I have a peace of mind that I never thought possible. 
Mark Dempster is author of Nothing to Declare: Confessions of an
Unsuccessful Drug Smuggler, Dealer and Addict, available now on Amazon. 
Mark runs a Harley Street counselling practice and is an expert consultant
and trainer in addiction, www.markdempstercounselling.com
FIRST PERSON
NOTHING 
TO DECLARE
In the sixth and final
part of his personal
story, Mark Dempster
experiences an 
unlikely epiphany
action
Last month Addiction Dependency
Solutions (ADS) held a seminal event
in parliament, Addiction to prescription
drugs, with the Labour shadow health
secretary, Andy Burnham.
The event was a Question Time
style debate on this topical issue and
consisted of a panel of clinicians,
service users and experts in their
respective fields, with direct
experience of addiction to
prescription drugs and treatment
services.
It was the first time an
event on this issue had
been held in parliament
and marked a momentous
day for many people in the
room who had been
campaigning for many years
for increased awareness of
the debilitating effects of
addiction to prescription
drugs such as
benzodiazepines. Addiction
to these drugs has
devastating and lasting
effects on individuals and
their families, and the
event highlighted the need
for increased provision of direct and
targeted treatment 
services for those who are addicted.
Currently, there is little treatment
available for those who suffer from
prescription drug addiction, with only
a handful of services dedicated to
this issue in the UK. As a progressive
charity, ADS aims to represent those
who need help the most. Working
with Oldham PCT and Barry Haslam
of Oldham Tranx (a voluntary support
group for those suffering from
addiction to prescription drugs) ADS
started providing an addiction to
prescription drug service in Oldham in
2004, and – by working with dynamic
commissioners – now provides
another service in Derby that was
recognised as a model of best
practice at the Westminster event.  
The event was chaired by Andy
Burnham MP and consisted of a panel
with Lady Rhona Bradley, chief
executive of ADS; Dr James Davies,
lecturer in social anthropology and
psychotherapy at Roehampton
University; Dr Jack Leach, consultant in
substance misuse; Dr Richard Martin,
assistant director of Public Health for
Derby Council; James Sutherland, lead
commissioner for public health for
Derby Council; Barry Haslam, chair of
Oldham Tranx and John, service
member of Oldham Tranx. Each
panellist had time to outline their own
background, experience and views on
addiction to prescription drugs before
the debate was widened, and
questions taken from the floor.
All the panellists were of the
opinion that addiction to prescription
drugs was an issue that had been
buried under the carpet for too long
and agreed that centralised action
was needed on a national scale to
offer guidance and results. Barry
Haslam drew on his own experience
of addiction to prescription drugs,
describing the lack of help he
received and the resultant health
problems he had suffered. This had
spurred him on to campaign
vociferously on the issue for the past
20 years.
One of the most striking
comments of the day came from Dr
James Davies. In discussing how
people were often ‘placed’ on
prescription drugs without getting to
the root of the problem – often as a
result of anxiety and stress – he said:
’Fifteen per cent of the British public
at one time are on some form of
prescription medication as a result of
mental health issues.’ This statistic
highlighted the scale of the problem,
with many of these drugs addictive
within four weeks and resulting in
dependence in as little as six weeks.
The panel’s consensus was shared
by the audience, with questions
reflecting the need for increased
political awareness and action. One
audience member, Dr Malcolm Lader,
drew on years of experience to
highlight the divisive role prescription
drugs were playing in our society, and
called for direct treatment to curb
their long-term ill-effects.
With a member of Public Health
England in attendance, it was left to
Andy Burnham to ask why current
guidelines and protocols for services
for prescription drug addiction were
so weak. The PHE response was, ‘It
is up to local authorities to take
action on the issue following
guidance from Public Health England.’
Andy Burnham responded: ‘That
doesn’t answer the question. Clearly
more needs to be done.’
As panellists drew on their
expertise and personal stories from
the audience mirrored their views,
there was little doubt about the scale
of the problem. Summarising,
Burnham said it was time to take
action on an issue that had been too
long ignored in parliament. As Labour
shadow health secretary, he would
aim to realign health and social care
as part of the NHS.
Lady Rhona Bradley said ADS
would continue to ‘champion a cause
that has clearly affected many in this
country, and an issue that should be
acted upon without haste.’
Tom Whiting is development and
grants officer at ADS
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Through a recent parliamentary debate, ADS brought 
together experts to tackle the pervasive problem of 
addiction to prescription drugs. Tom Whiting reports 
Prescription for 
’Fifteen per cent of
the British public 
at one time are on
some form of
prescription
medication as a
result of mental
health issues.’
DR JAMES DAVIES
Recovery | Fifth UK recovery walk
IN RECENT YEARS I’VE LEARNED THAT RECOVERY BECOMES CONTAGIOUS WITHIN
COMMUNITIES WHEN IT’S VISIBLE, when it’s seen and felt, and hope and
inspiration are passed on to those still struggling, still trying to define what
recovery means to them. This is most apparent at the UK recovery walks.  Anyone
who attended last year’s walk in Brighton will have seen and felt how powerful
the walk, a mobilisation of hope and optimism, can be. Looking down the hill in
the centre of Brighton last year I saw a crowd packed with happy faces, faces
filled with love and hope, faces once etched with pain and misery, now beaming
with gratitude in the September sun. Three thousand people marching up from
the beach joined in a desire to celebrate recovery in all its diversity. 
Whatever your view, or definition of recovery, it is hard to deny the
transformative effect of the recovery walks. While communicating a living
message of transformation and inclusion they have quite literally been ‘tipping
points’ for lots of people. As one Birmingham walker said to me, ‘I really needed
today. I love the feeling of belonging to something. I love knowing that all
around the country there are people like me, with the same struggles and fears,
and knowing that there is a way through this and I’m not alone.’
He wasn’t alone. I know of many people from the Midlands, where I live, who
came back inspired and determined to take control of their recovery. The
Brighton walk planning group passed on the baton (or, more accurately, a stick
of Brighton rock) to Birmingham. They’ve continued to build recovery in
Brighton as ‘creative cascade recovery’, and now it’s Birmingham’s turn to host
the UK’s biggest public recovery event. 
As the day comes ever nearer I’ve learnt many things about our recovery
community in Birmingham. We’ve come a long way together. We’ve had our highs
and lows. But what’s overwhelmed me as chair of the planning group is how
passionate, determined and enthusiastic our community is. We’ve discovered
skills and attributes we didn’t know existed. We’ve learnt to ask different
questions – ‘what are our strengths, our passions?’ – and unearthed a community
bubbling with strengths and assets. We’ve learnt that we need to look at what
we’ve got and not at what’s missing, and find the abundance within our own
communities. We’ve learnt that it’s not about what can be done for us but what
we can do for ourselves. Together we’ve become powerful and we’re really looking
forward to making new friends when we walk together on 22 September.
The walk is a powerful articulation of visible recovery, but we believe we can
do more. The UK recovery walk charity, established in April this year, will be
supporting walks from 2014 onwards. After the Birmingham walk I’ll be
focusing, in my role as a director with the UKRF, on the promotion and support
of a UK recovery month. Inspired by the recovery movement in the US, we want
to see September established as a month that makes recovery visible in every
city, town and village, speaking to everyone, offering hope to all. 
This year we’ve taken some small steps in preparation for 2014 when UK
recovery month will launch. We have some learning to do along the way and
we’ve decided to start the mini 2013 recovery month on top of a mountain.  
On 1 September, groups from all over the UK will gather at the top of
Snowdon in Wales for a cuppa and a chat. We’ll plant a purple flag (the colour of
recovery) at the top and we’ll reflect on what we’ve gained and what we’ve lost.
People will make their way to the summit in different ways, symbolising the
many different paths they have taken on their recovery journeys. 
This social gathering, for the UKRF, will mark a new beginning – a shedding of
past differences and an embracing of our common humanity. We all have
mountains to climb at some point in our lives. In coming together around our
similarities as human beings and in recognition of the validity of all paths we hope
to support the emerging UK recovery movement. Making the path as we walk it.
There will be other events in 2013 recovery month (that we know of) in
Derbyshire, Gloucestershire, Rochdale, Hertfordshire, Birmingham, Norfolk,
Lancashire, Kingston, Somerset and Cumbria. It’s a beginning and it will grow. 
To register for the UK recovery walk in Birmingham:
http://www.ukrw2013.co.uk/register 
For more info on 2013 Recovery Month:
https://www.facebook.com/groups/UKRecoveryFederation/ or contact:
alistair@ukrf.org.uk and richard.maunders@ukrf.org.uk
Richard Maunders is chair of the 2013 UK recovery walk Birmingham planning
group and UKRF director Alistair SinclairUKRF Director.
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On 22 September,
thousands of people 
will be gathering in
Birmingham for the 
fifth UK recovery walk, as
Richard Maunders explains
Soapbox | John Jolly
Soapbox
DDN’s monthly column
offering a platform for 
a range of diverse views. 
DOWNHILL
SLIDE
Our procurement, tendering and
commissioning processes are
unacceptably poor, says John Jolly
I’VE BEEN SHARING CONCERNS FOR YEARS with other CEOs and senior managers about
poor procurement and tendering in the drug and alcohol sector – usually just quietly,
over meetings with coffee. When I spoke recently to Martin Barnes, CEO at Drugscope,
the umbrella organisation for the field, we shared long-standing worries about the state
of commissioning in many areas.
To really address the issue, however, we need evidence of the impact on staff and
organisations, and examples of poor practice and waste. How much does it cost service
providers to tender? How much money do commissioners spend on consultants? We
cannot just complain about the process; we have to demonstrate its impact, unfairness,
and consequences for service users and on service provision and quality. It is perfectly
legitimate for local authorities to retender work provided to them by contractors, but in
the context of Big Society there needs to be a level playing field for the third sector and
local third sector providers.  
Poor and frequent commissioning has a number of serious consequences, not least of
which is the cost. An exercise to quantify the costs of tendering services more than years
ago came up with a figure of £300,000 expended by all bidders and the commissioner
per tender.
We have to accept that tendering of services is here to stay and that providers will all
win and lose contracts. However, I think there is a case to be made to increase from the
standard three-year contract to a seven- to- ten-year minimum contract length – or
possibly longer.
The contracts are often very one sided and allow cancellation with three or six
months notice. Often providers are asked to agree to the contract as a condition of being
allowed to tender, which is clearly unfair. Contracts need to be far less easy for local
authorities to wriggle out of, with an expectation that any but the most major changes
required are done via contract variation rather than retendering, except where there are
clear performance issues.
At Blenheim we are concerned about the minimum turnover requirements that are
beginning to affect the ability of small providers to tender for contracts they currently hold.
This is where to bid for work you have to have a minimum turnover of, say, £5m or £10m. I
am aware of many smallish and medium-sized charities that have not been able to bid for
their own contracts back in their own right, forcing them into shotgun marriages with
other providers as junior partners. This has on occasions included Blenheim, despite us
being in the top 750 charities in the UK by income out of 66,000 charities.
Partnerships have a lot to offer and Blenheim is in many great and highly effective
partnerships, but they rarely work well when they are marriages of convenience. 
Blenheim is concerned that we are starting to see the demise of local third sector
organisations operating and attuned to local communities, and their replacement by
profit-motivated or organisational-survival-motivated or growth-driven organisations.
This I already hear and see impacting detrimentally on service provision.  
Blenheim is concerned about minimum standards in the drug and alcohol sector, with
the move to local authority commissioning and the demise of the National Treatment
Agency. Providers are all being forced to compete on price rather than quality, and this has
a direct impact on who is employed or made redundant. The people that service providers
employ and their skills and ability is what makes the difference to the mothers, fathers,
children, sisters, uncles, neighbours, friends and grandparents with a drug or alcohol
problem that we are here to help. These people deserve a quality service, delivered against
exacting standards of performance and staff competence, not the cheapest available.
Blenheim is deeply troubled about the many instances of poorly managed tendering
processes which create huge wastes of time and effort both at commissioning level and
within provider organisations. This is now a regular occurrence and issues have included
unfair decisions, lack of transparency about the process, and lack of knowledge about
tendering and procurement within tendering teams. A number of tendering processes
have to be suspended due to flaws in the process, and there is complete lack of
understanding by many commissioners of TUPE rules. There are attempts to dump
significant pension liabilities on incoming organisations where the NHS or local authority
is the outgoing organisation, and there are sometimes completely ludicrous and
unworkable specifications. Local authorities often transfer risk to providers via payment
by results with poor data to assess risk – often in relation to performance targets the
provider has little control over.
At Blenheim we think its time we should stop talking and start acting, as a provider
and a sector, to raise these concerns via DrugScope and other forums.
John Jolly is chief executive of Blenheim CDP
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How can we support families
to cope with the many facets
of their loved ones’ addiction? 
The Families First conference brings together family
members, treatment and support professionals and those
who are willing to share their expertise from experience, to
create a highly valuable one-day event.
Through a programme steered by premier family support
charity Adfam, it will offer inspiring examples of ongoing
support, effective coping mechanisms, useful legal know -
ledge, and essential networking, to better equip family
members and those who support them to deal with the
challenges of addiction in the family.
This is the annual must-attend event for family members
affected by substance use and for all agencies and organisa -
tions who genuinely want to support them.
EARLY BIRD DELEGATE RATES 
for bookings before Friday 20 September
Family members £80 + vat
Professionals £135 + vat
Joint ticket special offer: One family member plus one
professional – £195 + vat (save £20)
(An additional £10 will be added to bookings made after this date)
Full programme and online booking at
www.drinkanddrugsnews.com
e: conferences@cjwellings.com  t: 01233 633 315
FamiliesFirst
Thursday, 21 November 2013 – BIRMINGHAM
The 2nd Adfam/DDN family conference
Putting families at the centre of recovery
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CASSIOBURY COURT
RECOVER REBALANCE RENEW
• Specialising in Addiction & dual
diagnosis
• CQC Registered 
• 13 Bed fully residential centre in Watford
• Set in our own beautiful grounds
• Single rooms
• Detox and Rehabilitation facility
• Detox from Alcohol and/or drugs
• 10day to 28day detox program
• 24 hour care
• Psychiatric assessment on arrival
• Pre admission assessment required
• Holistic approach 
• Structured day care program
• Excellent out comes
• Links to family and support groups
• In house chef providing all nutritious
meals
• Excellent links to M1, M25, London
(15mins) & Airports
• Pick up from stations
• Block and spot purchased beds
Referrals accepted across the UK.
Working with DAAT Teams, DIP Teams & Social Services. 
For enquiries please call Darren, Admissions Director, on 
01923 804139 or 0800 5003129 or email darren@cassioburycourt.com
www.cassioburycourt.com
*
+44 (0)1502 587269
www.eastcoastrecovery.co.uk
• Altered attitudes 12 Step Recovery Programme
• Primary (0-12 weeks), Secondary (12 – 24 weeks)
and tertiary care (24 weeks+) (Foundation,
Support and development packages)
• The UK’s first ‘Recovery Stuff’ retail outlet
• Asset based Community Development
• CBT/NLP/Creative Workshops/Psychodrama,
Adventurous activity, Family Intervention
workshops
• Pathways to education, employment and housing
• Continuous aftercare – 12 step facilitation
network
CQC registered
Find us on
Facebook
at /eastcoastrecovery
Recovery at its best
OUTSTANDING EMPLOYER OF THE YEAR
Awarded by the Suffolk Brokerage, May 2013
OUTSTANDING CONTRIBUTION TO RECOVERY
Presented by the NTA and voted for by service users BAYTREES
RECOVERY FOCUSSED DETOX CENTRE
• Specialists in Dual Diagnosis and complex issues
• 24/7 support from clinical and therapeutic team
• Structured Recovery focussed group workshops and regular one to ones
• Access to additional services - physiotherapist, dietician, 
dental hygienist, bbv testing
• 23 individual bedrooms and ground floor ensuite room
• Links to family and carer support groups
• Daily complimentary therapies 
• High completion rates
• Sensory room
Referrals accepted from all regions. 
For enquiries please call Karen Morris, Clinical Manager, 
on 02392 683370 or email: karen.morris@solent.nhs.uk
www.solent.nhs.uk/baytrees
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Community Alcohol Treatment
and Recovery Services
EXPRESSIONS OF INTEREST
Swindon Borough Council Drug and Alcohol Action Team (Swindon DAAT) invite
expressions of interest from suitably qualified and experienced service providers for the
provision of an Adult Community Alcohol Treatment and Recovery Service throughout the
Borough of Swindon, serving a population of approximately 210,000 residents.
The Adult Community Alcohol Treatment and Recovery Service is a newly designed,
recovery focussed service where a successful provider will ensure seamless and
accessible pathways for service users by providing: 
• Intake Team
• Hospital Alcohol Liaison
• Clinical Service
• Recovery, Support and Transition Service
Full details relating to the four service elements will be provided in the Invitation to
Tender (ITT) document.
The resources, range and depth of skills needed to provide the service are such that
some organisations may wish to collaborate to form a consortium in order to bid, with a
lead organisation becoming the main contracting party with Swindon Borough Council.
However, this does not preclude a single provider tendering all the resources and
services required by the Invitation to Tender.
The contract will be initially for a period of 3 years commencing 1 April 2014 with an
option to extend for a further 12 months subject to satisfactory performance. This is a
competitive tender, and a contract will be awarded to the organisation that is deemed to
represent the most economically advantageous tender.
Organisations wishing to Register Interest and download ITT documents which will go live
on 09 September 2013, should apply via the South West Portal using the following URL link:
https://www.supplyingthesouthwest.org.uk/procontract/supplier.nsf/frm_home?openForm
Click on “Search Latest Opportunities” and locate Contract ID SWCE-9A4DZB
If you have any problems with this link, please email the contact Jennifer Laibach at
JLaibach@swindon.gov.uk and Kate Daniels KMDaniels@swindon.gov.uk
The closing date for the receipt of completed tenders is 12 noon on 09 October 2013
Tender for the provision of a 
DRUG AND ALCOHOL INTEGRATED TREATMENT SERVICE
(Southampton City). 
Final deadline for PPQs, 27 August (midday)
See the full tender information on
www.drinkanddrugsnews.com
TENDER
Kairos Community Trust is a leading alcohol and drug treatment provider,
with over 21 years’ experience. We are looking for an experienced,
enthusiastic and committed people to join our team.
Manager, Supported Housing Team
Counsellor, Residential Rehab, (Full time 3 month contract)
Post CVs to 235 Valley Road, London SW16 2AF
Closing date: 16th August 2013
For more information email kairosoffice@kairoscommunity.org.uk 
or visit www.kairoscommunity.org.uk
COUNSELLOR
£Neg    Luton
We are seeking a part qualified/
qualified counsellor with some working
knowledge of the 12 step model. 
PCP have been established for nearly
10 years as a residential rehab treating
both private and public funding
clients. Experience with group therapy
would be an advantage but not
essential. You will be part of a small
friendly team of professionals. 
www.rehabtoday.com
Please contact Perry Clayman or James Peacock on 01582 730113
or email your CV to info@pcpluton.com
Luton, Chelmsford, London
CARRINGTON HOUSE HOTEL – BOURNEMOUTH
More info at NNEF.ORG.UK
This event 
will showcase 
latest practice,
develop ments
and issues for
needle and
syringe pro -
gram mes in
England. The
day is tailored
to the needs 
of programme
work ers and
service users
across the
country.
See these and more jobs at
www.drinkanddrugsnews.com 
To advertise your vacancy, in print, online and 
via email contact ian@cjwellings.com
SUBSTANCE
MISUSE DOCTOR
London 
INFORMATION
MANAGER QUALITY 
AND PERFORMANCE
London
GENERAL AND
MENTAL HEALTH
NURSES
Gloucestershire
PARENT SUPPORT
WORKER
West London, UK
YOUNG PEOPLES
NURSE
Scarborough
OPERATIONS
MANAGER –
SUBSTANCE
MISUSE SERVICES
Gloucestershire 
SERVICE
MANAGER –
SUBSTANCE
MISUSE SERVICE
Hampshire
C R I M I N A L  J U S T I C E
To find your next job please visit:
sanctuarycriminaljustice.com  
or call 0800 046 1116
       
LETTINGS AND PROPERTY 
MANAGEMENT COORDINATOR
DHI, Bath, Bristol • £19,621 pro-rata
Working for Home Turf Lettings, DHI’s not-for-profit residential lettings agency, you
will guide and assist tenants to move into their new home and support them to be
successful in their tenancies. Experience of working in a lettings and property
management setting is desirable but not essential. If you have an organised, flexible
and common sense approach and a genuine desire to improve the lives of those who
are in housing need then we want to hear from you. 
For more details visit   www.dhi-online.org.uk/jobs/
or call   01225 478730
087 – Community Nurse (Prescriber)
Loughborough. Closing date: 29 August 2013.
Swanswell’s Community Nurse Prescriber’s support our Operations Managers to
deliver quality services and go the extra mile for our service users. You will oversee
community drug and alcohol detoxifications and facilitate prescribing clinics across
Leicestershire. You will also provide BBV screenings and vaccinations and support
substance misuse workers in managing the health needs to our service users.
You must be a registered nurse (RGN, RMN), preferably with a non medical
prescribing(NMP) qualification and a current PIN or a willingness to work towards
obtaining an NMP qualification. This is a full time post. 
088 – Clinical Operations Manager
Loughborough. Closing date: 29 August 2013.
Swanswell Operations Managers are responsible for making sure our services
provide effective support. You will manage a team of workers which includes our
medical staff and substance misuse workers. A large part of this role will be
ensuring that our services are meeting their targets, exceeding expectations and
compliant with quality standards. So you’ll need to be able to provide effective
support to a team of workers, monitoring casework (including service user care
plans) and addressing any performance issues. This will include the auditing of
caseloads to ensure a high standard of care is being delivered against required
standards.
You must be a registered nurse (RGN, RMN) with a non medical prescribing
qualification and a current PIN. This is a full time post. 
085 – Accredited Programmes Facilitators (Two vacancies)
Coventry and Stafford. Closing date: 23 August 2013.
Swanswell’s Accredited Programmes Facilitators deliver substance misuse accredited
programmes to offenders referred by the National Probation Service (NPS). You’ll be
required to deliver a range of substance misuse programmes, including the Drink
Impaired Drivers Programme (DIDP), the Lower Intensity Alcohol Programme (LIAP), the
Offender Substance Abuse Programme (OSAP) and the Building Skills for Recovery
programme (BSR). You must be accredited in at least one of these programmes and be
able to provide evidence of delivering a programme in the last 12 months.
This is a part time post, working approximately 18 hours per week (this is subject to
change dependent on the needs of the business, and will be discussed at interview).
There may be a possibility of combining this role with another Swanswell role to make a
full time position. 
086 – Clinical Senior Practitioner 
Loughborough. Closing date: 29 August 2013.
Swanswell Senior Practitioners support our Operations managers to deliver quality
services. You will supervise a team of workers including our medical team members,
motivating them to deliver quality services and go the extra mile for our service users. 
You will be expected to supervise our nursing teams in the delivery of community
detoxifications and ensure that their practice is safe and effective. You will also manage a
team of substance misuse workers and will provide supervision, case file audits and
observations in order to ensure an excellent level of service delivery.
You must be a registered nurse (RGN, RMN) with a non medical prescribing qualification
and a current PIN. This is a full time post. 
Swanswell is a national alcohol and drug charity that helps people
change and be happy. We believe in a society free from problem alcohol
and drug use. We are currently recruiting for the following positions:
To apply for any of these roles, please visit our website, www.swanswell.org/current-vacancies. 
If you would like to discuss any of the roles or enquire about our recruitment process, please email us on jobs@swanswell.org or call us on 01788 559 400 (HR).
